Sign up to save your podcasts
Or
Share Update on heart failure and diabetes: what is the potential role of semaglutide and the combination of GIP-GLP1 receptor agonists in the management of HF?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Update on heart failure and diabetes: what is the potential role of semaglutide and the combination of GIP-GLP1 receptor agonists in the management of HF?
With Nikolaus Marx, Chair of Task Force of the 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes, RWTH University Hospital Aachen, Aachen - Germany and Ruxandra Christodorescu, University of Medicine and Pharmacy Victor Babes, Timisoara - Romania.
In this podcast, Nikolaus Marx joins Ruxandra Christodorescu to discuss updates on heart failure and diabetes: what is the potential role of semaglutide and the combination of GIP-GLP1 receptor agonists in the management of HF?
View all episodes
By European Society of CardiologyWith Nikolaus Marx, Chair of Task Force of the 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes, RWTH University Hospital Aachen, Aachen - Germany and Ruxandra Christodorescu, University of Medicine and Pharmacy Victor Babes, Timisoara - Romania.
In this podcast, Nikolaus Marx joins Ruxandra Christodorescu to discuss updates on heart failure and diabetes: what is the potential role of semaglutide and the combination of GIP-GLP1 receptor agonists in the management of HF?More shows like CardioPractice Cardio Talk
View all
JACC This Week
171 Listeners
This Week in Cardiology
872 Listeners
Circulation on the Run
31 Listeners
Eagle's Eye View: Your Weekly CV Update From ACC.org
135 Listeners
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
60 Listeners
ESC Cardio Talk
17 Listeners
Cardionerds: A Cardiology Podcast
425 Listeners
Mayo Clinic Cardiovascular CME
38 Listeners